Lite Strategy, Inc. Increase (Decrease) in Commodity Contract Assets and Liabilities
Lite Strategy, Inc. (LITS) reported Increase (Decrease) in Commodity Contract Assets and Liabilities of $4.72 million for the 12-month period ending 2021-06-30, per its 10-K filed 2021-09-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInCommodityContractAssetsAndLiabilities · last filed 2021-09-02
- Lite Strategy, Inc. increase (decrease) in commodity contract assets and liabilities for fiscal 2021 was $4.72M, a 101.28% increase from fiscal 2020.
- Lite Strategy, Inc. increase (decrease) in commodity contract assets and liabilities for fiscal 2020 was $2.35M, a 1079.40% increase from fiscal 2019.
- Lite Strategy, Inc. increase (decrease) in commodity contract assets and liabilities for fiscal 2019 was $199.00K.
| Period end | Increase (Decrease) in Commodity Contract Assets and Liabilities 12 month |
|---|---|
| 2021-06-30 | $4.72M 10-K · filed 2021-09-02 |
| 2020-06-30 | $2.35M 10-K · filed 2021-09-02 |
| 2019-06-30 | $199.00K 10-K · filed 2021-09-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |